Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.
2023/49/N/NZ7/03096
Keywords
Descriptors
- NZ7_16: Inne zagadnienia pokrewne
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 22 – announced on 2023-03-16
- Amount awarded
- 210 000 PLN
- Project start date
- 2024-01-17
- Project end date
- 2027-01-16
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.